Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors
Stopped Loss of funding
Conditions
- Metastatic Malignant Neoplasm in the Brain
- Primary Brain Neoplasm
Interventions
- PROCEDURE: 3 Tesla Magnetic Resonance Imaging
- PROCEDURE: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- PROCEDURE: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
- DRUG: Ferumoxytol
- DRUG: Gadolinium
- PROCEDURE: High Field Strength Magnetic Resonance Imaging
- PROCEDURE: Susceptibility Weighted Imaging
Sponsor
OHSU Knight Cancer Institute
Collaborators
- [object Object]
- [object Object]